JPS5877813A - 抗菌剤 - Google Patents
抗菌剤Info
- Publication number
- JPS5877813A JPS5877813A JP57175228A JP17522882A JPS5877813A JP S5877813 A JPS5877813 A JP S5877813A JP 57175228 A JP57175228 A JP 57175228A JP 17522882 A JP17522882 A JP 17522882A JP S5877813 A JPS5877813 A JP S5877813A
- Authority
- JP
- Japan
- Prior art keywords
- activity
- antibacterial
- minutes
- general formula
- antibacterial activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000844 anti-bacterial effect Effects 0.000 title description 16
- 125000004429 atom Chemical group 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 description 13
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 10
- 239000003242 anti bacterial agent Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 5
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 5
- 229960003260 chlorhexidine Drugs 0.000 description 5
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 5
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 241000607720 Serratia Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000002815 broth microdilution Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT24318A/81 | 1981-10-05 | ||
| IT24318/81A IT1153988B (it) | 1981-10-05 | 1981-10-05 | Composizioni ad attivita' antimicrobica |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5877813A true JPS5877813A (ja) | 1983-05-11 |
| JPS6153323B2 JPS6153323B2 (enExample) | 1986-11-17 |
Family
ID=11213078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57175228A Granted JPS5877813A (ja) | 1981-10-05 | 1982-10-04 | 抗菌剤 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0076430B1 (enExample) |
| JP (1) | JPS5877813A (enExample) |
| DE (2) | DE76430T1 (enExample) |
| IT (1) | IT1153988B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6348113B1 (en) | 1998-11-25 | 2002-02-19 | Cabot Corporation | High purity tantalum, products containing the same, and methods of making the same |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2550192B1 (fr) * | 1983-08-03 | 1986-04-04 | Sanofi Sa | Nouveaux derives de la benzamidine a activite antimicrobienne, leur procede de preparation, leur utilisation en tant que medicaments desinfectants ou conservateurs |
| JPH0610121U (ja) * | 1991-12-26 | 1994-02-08 | 本州製紙株式会社 | 展示用箱 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2042528B (en) * | 1979-02-08 | 1983-05-25 | Ube Industries | Benzamidine derivatives process for preparing the same and fungicidal compositions containing the same |
-
1981
- 1981-10-05 IT IT24318/81A patent/IT1153988B/it active
-
1982
- 1982-09-22 EP EP82108759A patent/EP0076430B1/en not_active Expired
- 1982-09-22 DE DE198282108759T patent/DE76430T1/de active Pending
- 1982-09-22 DE DE8282108759T patent/DE3271781D1/de not_active Expired
- 1982-10-04 JP JP57175228A patent/JPS5877813A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6348113B1 (en) | 1998-11-25 | 2002-02-19 | Cabot Corporation | High purity tantalum, products containing the same, and methods of making the same |
| US6893513B2 (en) | 1998-11-25 | 2005-05-17 | Cabot Corporation | High purity tantalum, products containing the same, and methods of making the same |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0076430A1 (en) | 1983-04-13 |
| JPS6153323B2 (enExample) | 1986-11-17 |
| EP0076430B1 (en) | 1986-06-18 |
| DE3271781D1 (en) | 1986-07-24 |
| DE76430T1 (de) | 1985-08-14 |
| IT1153988B (it) | 1987-01-21 |
| IT8124318A0 (it) | 1981-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kull et al. | Mixtures of quaternary ammonium compounds and long-chain fatty acids as antifungal agents | |
| Fukuda et al. | Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection: efficacy of chloramphenicol eye drops | |
| US4784991A (en) | Heavy metal salts of hyaluronic acid and their use as antimicrobial agents | |
| Bridges et al. | Drug resistance in relation to use of silver sulphadiazine cream in a burns unit. | |
| CA1330946C (en) | Topical preparation for treating otopathy containing ofloxacin or a salt thereof | |
| AU3860199A (en) | Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives | |
| Minagawa et al. | Effects of pH on the activity of ketoconazole against Candida albicans | |
| Shen et al. | A chelating agent possessing cytotoxicity and antimicrobial activity: 7-morpholinomethyl-8-hydroxyquinoline | |
| Scholer | Antimykoticum 5‐Fluorocytosin (Oral Antimycotic Agent, 5‐Fluorocytosine) | |
| Koerner et al. | Povidone-iodine concentration and in vitro killing time of bacterial corneal ulcer isolates | |
| CN115768517B (zh) | 非人类动物用抗菌剂 | |
| JPS5877813A (ja) | 抗菌剤 | |
| Khardori et al. | Comparative in-vitro activity of twenty antimicrobial agents against clinical isolates of Mycobacterium avium complex | |
| WO2001000226A1 (fr) | Pommade ophtalmique pour traiter les maladies infectieuses | |
| CN118373882B (zh) | 一种抗铜绿假单胞菌多肽、抗菌多肽溶液及应用 | |
| Yu et al. | Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa | |
| SERY et al. | Novobiocin, a new antibiotic: ocular penetration and tolerance | |
| US5470875A (en) | Water soluble, antimicrobial compositions of polyhexamethylene biguanide and iodopropynylbutyl carbamate | |
| Milne et al. | Piperacillin, a new penicillin with high anti-pseudomonal activity | |
| Sugar et al. | Treatment of experimental Pseudomonas corneal ulcers with enoxacin, a quinolone antibiotic | |
| US4897404A (en) | Anti-infective methods and compositions | |
| CN120514715B (zh) | 磺胺类化合物的应用、结核分枝杆菌抑制剂、药物组合物及其应用 | |
| Hatano et al. | Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits | |
| RU2143905C1 (ru) | Применение солей полигексаметиленгуанидиния в качестве препаратов, обладающих антимикробной активностью по отношению к анаэробной и смешанной инфекции | |
| US3629414A (en) | Antibacterial and synergistic antifungal compositions |